Arrayit Corporation (ARYC) has leveraged the company’s patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson’s Disease (PD). This important research project offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson’s Diagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules
Arrayit Corporation (ARYC) reports microarray printer inquiry from the United States Food and Drug Administration FDA. ARYC supplies the world's top agencies!! (when the FDA wants to order your products that is HUGE!!)
Arrayit Corporation (ARYC) microarray technology is being used in search of neurological disorder cures, human stem cells arrays.
May 13, 2015 Arrayit Corporation (ARYC) announced an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth.
As of March 31, 2015, Arrayit Corporation (ARYC) owned an equity interest in Avant Diagnostics, Inc. through ownership of 41.7%
Arrayit Corporation (ARYC) has a fantastic share structure:
Follow Sierra on Twitter To Get The Next PUBLISHER ALERT~~Follow Sierra on Twitter
Every day we present our publisher's pick where we profile a stock that our publisher has taken a position in, we believe that the stock is extremely undervalued with potential for significant percentage gains. We also issue short term daily buy or sell ratings with 5 day price targets for stocks in all industries across all markets and make speculative predictions on potential joint ventures, mergers and acquisitions.